Menu Search
Equities

Vincent Medical Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1612:HKG.HZ

Vincent Medical Holdings Ltd

Actions
  • Price (HKD)1.02
  • Today's Change0.01 / 0.99%
  • Shares traded116.00k
  • 1 Year change+155.00%
  • Beta0.7603
Data delayed at least 15 minutes, as of Feb 16 2026 02:36 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Vincent Medical Holdings Ltd is an investment holding company principally engaged in the research and development, manufacturing and sales of medical devices business. The Company is mainly engaged in the production of electronic medical devices, high-flow oxygen therapy devices, respiratory humidification systems, rehabilitation equipment, respiratory care and anesthesia-related consumables.

  • Revenue in HKD (TTM)869.70m
  • Net income in HKD87.51m
  • Incorporated2015
  • Employees1.46k
  • Location
    Vincent Medical Holdings LtdFlat B2, 7/F., Phase 2, Hang Fung Indust2G Hok Yuen Street, Hung Hom, KowloonPO Box 2681 Hong KongHKG
  • Phone+852 21552998
  • Fax+852 21558298
  • Websitehttps://www.vincentmedical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.